{
    "Rank": 720,
    "Study": {
        "ProtocolSection": {
            "IdentificationModule": {
                "NCTId": "NCT05581979",
                "OrgStudyIdInfo": {
                    "OrgStudyId": "PSMA 01"
                },
                "Organization": {
                    "OrgFullName": "National Cancer Centre, Singapore",
                    "OrgClass": "OTHER"
                },
                "BriefTitle": "PSMA-PET Imaging of Salivary Gland Tumours and Other Rare Cancers",
                "OfficialTitle": "PSMA-PET Imaging of Salivary Gland Tumours and Other Rare Cancers"
            },
            "StatusModule": {
                "StatusVerifiedDate": "October 2022",
                "OverallStatus": "Recruiting",
                "ExpandedAccessInfo": {
                    "HasExpandedAccess": "No"
                },
                "StartDateStruct": {
                    "StartDate": "January 26, 2022",
                    "StartDateType": "Actual"
                },
                "PrimaryCompletionDateStruct": {
                    "PrimaryCompletionDate": "June 2023",
                    "PrimaryCompletionDateType": "Anticipated"
                },
                "CompletionDateStruct": {
                    "CompletionDate": "June 2024",
                    "CompletionDateType": "Anticipated"
                },
                "StudyFirstSubmitDate": "September 28, 2022",
                "StudyFirstSubmitQCDate": "October 11, 2022",
                "StudyFirstPostDateStruct": {
                    "StudyFirstPostDate": "October 17, 2022",
                    "StudyFirstPostDateType": "Actual"
                },
                "LastUpdateSubmitDate": "October 11, 2022",
                "LastUpdatePostDateStruct": {
                    "LastUpdatePostDate": "October 17, 2022",
                    "LastUpdatePostDateType": "Actual"
                }
            },
            "SponsorCollaboratorsModule": {
                "ResponsibleParty": {
                    "ResponsiblePartyType": "Sponsor"
                },
                "LeadSponsor": {
                    "LeadSponsorName": "National Cancer Centre, Singapore",
                    "LeadSponsorClass": "OTHER"
                }
            },
            "OversightModule": {
                "OversightHasDMC": "No",
                "IsFDARegulatedDrug": "No",
                "IsFDARegulatedDevice": "No"
            },
            "DescriptionModule": {
                "BriefSummary": "The objectives of this pilot feasibility study, which is on the use of 68-Ga PSMA PET imaging of salivary gland tumours, are\n\nto determine the proportion of patients with high PSMA-ligand uptake on Ga-68 PSMA imaging in locally advanced, recurrent or metastatic salivary gland cancers and other rare cancer; and\nto determine if in vitro PSMA expression correlates to PSMA-ligand uptake on Ga-68 PSMA imaging in locally advanced, recurrent or metastatic salivary gland cancers and other rare cancers.\n\nThe hypotheses of this study are that there is high PSMA-ligand uptake on Ga-68 PSMA imaging in locally advanced, recurrent or metastatic salivary gland cancers and other rare cancers; and that in vitro PSMA expression correlates to PSMA-ligand uptake on Ga-68 PSMA imaging.",
                "DetailedDescription": "The potential participant will be screened and confirmed for eligibility by the appropriate study-team member. A signed IRB approved informed consent will be obtained prior to conducting any study-related procedures.\n\nOn the scheduled visit date for the study,\n\nAn intravenous cannula (plug) will be inserted in a vein in the participant's arm, through which the 68-Ga PSMA radiotracer for the scan will be injected. The infusion will take about 1-2 minutes.\nPET imaging will be performed with a dedicated PET/CT scanner. 2.5-6.0 mCi (depending on weight of the patient) of PSMA radiotracer will be injected intravenously.\nA PET scan will be done around 60 minutes after the injection of the 68-Ga PSMA imaging agent.\nDuring imaging, the participant will be asked to lie still and may be asked to hold his/her breath for a few seconds.\nImaging will be performed using a PET/CT, which will take 30 to 40 minutes to complete. Imaging of the body from vertex to mid thigh or feet will be obtained.\nAfter the completion of the scan, the plug will be removed.\n\nA Final Study Visit will take place on that one scheduled day. The participant will not need to visit the doctor's office during the course of the study outside of their usual scheduled doctor's follow up appointments."
            },
            "ConditionsModule": {
                "ConditionList": {
                    "Condition": [
                        "Salivary Gland Tumor",
                        "Rare Malignant Neoplasm"
                    ]
                },
                "KeywordList": {
                    "Keyword": [
                        "68-Ga PSMA PET Imaging",
                        "Salivary Gland",
                        "Radiolabeling",
                        "Gallium-68",
                        "PET scan",
                        "Prostate Specific Membrane Antigen",
                        "Adenocystic Carcinoma",
                        "Rare Tumours"
                    ]
                }
            },
            "DesignModule": {
                "StudyType": "Observational",
                "PatientRegistry": "No",
                "DesignInfo": {
                    "DesignObservationalModelList": {
                        "DesignObservationalModel": [
                            "Cohort"
                        ]
                    },
                    "DesignTimePerspectiveList": {
                        "DesignTimePerspective": [
                            "Prospective"
                        ]
                    }
                },
                "EnrollmentInfo": {
                    "EnrollmentCount": "24",
                    "EnrollmentType": "Anticipated"
                }
            },
            "ArmsInterventionsModule": {
                "ArmGroupList": {
                    "ArmGroup": [
                        {
                            "ArmGroupLabel": "68-Ga PSMA PET scan",
                            "ArmGroupDescription": "68-Ga PSMA PET scan",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Diagnostic Test: 68-Ga PSMA PET scan"
                                ]
                            }
                        }
                    ]
                },
                "InterventionList": {
                    "Intervention": [
                        {
                            "InterventionType": "Diagnostic Test",
                            "InterventionName": "68-Ga PSMA PET scan",
                            "InterventionDescription": "On the scheduled visit date for the study,\n\nAn intravenous cannula (plug) will be inserted in a vein in the participant's arm, through which the 68-Ga PSMA radiotracer for the scan will be injected. The infusion will take about 1-2 minutes.\nPET imaging will be performed with a dedicated PET/CT scanner. 2.5-6.0 mCi (depending on weight of the patient) of PSMA radiotracer will be injected intravenously.",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "68-Ga PSMA PET scan"
                                ]
                            }
                        }
                    ]
                }
            },
            "OutcomesModule": {
                "PrimaryOutcomeList": {
                    "PrimaryOutcome": [
                        {
                            "PrimaryOutcomeMeasure": "The proportion of patients with high PSMA-ligand uptake on Ga-68 PSMA imaging in locally advanced, recurrent or metastatic salivary gland cancers and other rare cancer.",
                            "PrimaryOutcomeDescription": "The proportion of patients with PSMA-ligand uptake greater than liver uptake on Ga-68 PSMA imaging in locally advanced, recurrent or metastatic salivary gland cancers and other rare cancer.",
                            "PrimaryOutcomeTimeFrame": "Through study completion, to June 2024."
                        }
                    ]
                },
                "SecondaryOutcomeList": {
                    "SecondaryOutcome": [
                        {
                            "SecondaryOutcomeMeasure": "Correlation between in vitro PSMA expression and PSMA-ligand uptake on Ga-68 PSMA imaging in locally advanced, recurrent or metastatic salivary gland cancers and other rare cancers.",
                            "SecondaryOutcomeDescription": "Correlation between the value of IHC PSMA expression and the PSMA PET SUVmax in locally advanced, recurrent or metastatic salivary gland cancers and other rare cancers.",
                            "SecondaryOutcomeTimeFrame": "Through study completion, to June 2024."
                        }
                    ]
                }
            },
            "EligibilityModule": {
                "EligibilityCriteria": "Inclusion Criteria:\n\nLocally advanced, metastatic or locally recurrent salivary gland cancers OR rare cancers (Examples of rare cancers: thyroid ca, cholangio ca, pancreatic ca, gall bladder ca, sarcoma)\nSample of biopsied tissue available for analysis\nHistologically confirmed diagnoses\nAbove 21 years of age\nAble to provide informed consent\n\nExclusion Criteria:\n\nThose who do not meet above inclusion criteria\nDiagnosis of haematological malignancies\nPatients with more than one cancer diagnosis\n\nContraindication to 68Ga-PSMA PET/CT\n\nE.g.: pregnant patients, breast feeding patients, renal impairment, liver impairment, allergy to components of the test\nAny psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow up schedule\nOngoing participation in any other clinical trial",
                "HealthyVolunteers": "No",
                "Gender": "All",
                "MinimumAge": "21 Years",
                "MaximumAge": "99 Years",
                "StdAgeList": {
                    "StdAge": [
                        "Adult",
                        "Older Adult"
                    ]
                },
                "StudyPopulation": "Patients would have to have histologically confirmed diagnoses, are above 21 years of age, have no contraindication to 68Ga-PSMA PET/CT and able to give consent.",
                "SamplingMethod": "Non-Probability Sample"
            },
            "ContactsLocationsModule": {
                "CentralContactList": {
                    "CentralContact": [
                        {
                            "CentralContactName": "Dr Wen-Long NEI, MD",
                            "CentralContactRole": "Contact",
                            "CentralContactPhone": "+65 64368000",
                            "CentralContactEMail": "nei.wen.long@singhealth.com.sg"
                        }
                    ]
                },
                "OverallOfficialList": {
                    "OverallOfficial": [
                        {
                            "OverallOfficialName": "Dr Wen-Long NEI, MD",
                            "OverallOfficialAffiliation": "National Cancer Centre, Singapore",
                            "OverallOfficialRole": "Principal Investigator"
                        }
                    ]
                },
                "LocationList": {
                    "Location": [
                        {
                            "LocationFacility": "National Cancer Centre Singapore",
                            "LocationStatus": "Recruiting",
                            "LocationCity": "Singapore",
                            "LocationZip": "169610",
                            "LocationCountry": "Singapore",
                            "LocationContactList": {
                                "LocationContact": [
                                    {
                                        "LocationContactName": "Dr Wen-Long NEI, MD",
                                        "LocationContactRole": "Contact"
                                    },
                                    {
                                        "LocationContactName": "Dr Kelvin LOKE, MD",
                                        "LocationContactRole": "Principal Investigator"
                                    }
                                ]
                            }
                        }
                    ]
                }
            },
            "IPDSharingStatementModule": {
                "IPDSharing": "Undecided"
            }
        },
        "DerivedSection": {
            "MiscInfoModule": {
                "VersionHolder": "September 08, 2023"
            },
            "ConditionBrowseModule": {
                "ConditionMeshList": {
                    "ConditionMesh": [
                        {
                            "ConditionMeshId": "D000009369",
                            "ConditionMeshTerm": "Neoplasms"
                        },
                        {
                            "ConditionMeshId": "D000012468",
                            "ConditionMeshTerm": "Salivary Gland Neoplasms"
                        }
                    ]
                },
                "ConditionAncestorList": {
                    "ConditionAncestor": [
                        {
                            "ConditionAncestorId": "D000009062",
                            "ConditionAncestorTerm": "Mouth Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000006258",
                            "ConditionAncestorTerm": "Head and Neck Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000009371",
                            "ConditionAncestorTerm": "Neoplasms by Site"
                        },
                        {
                            "ConditionAncestorId": "D000009059",
                            "ConditionAncestorTerm": "Mouth Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000009057",
                            "ConditionAncestorTerm": "Stomatognathic Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000012466",
                            "ConditionAncestorTerm": "Salivary Gland Diseases"
                        }
                    ]
                },
                "ConditionBrowseLeafList": {
                    "ConditionBrowseLeaf": [
                        {
                            "ConditionBrowseLeafId": "M5224",
                            "ConditionBrowseLeafName": "Carcinoma",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M6423",
                            "ConditionBrowseLeafName": "Carcinoma, Adenoid Cystic",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M14977",
                            "ConditionBrowseLeafName": "Salivary Gland Neoplasms",
                            "ConditionBrowseLeafAsFound": "Salivary Gland Tumors",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M11712",
                            "ConditionBrowseLeafName": "Mouth Neoplasms",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M9038",
                            "ConditionBrowseLeafName": "Head and Neck Neoplasms",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M11709",
                            "ConditionBrowseLeafName": "Mouth Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M11707",
                            "ConditionBrowseLeafName": "Stomatognathic Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M14975",
                            "ConditionBrowseLeafName": "Salivary Gland Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "T201",
                            "ConditionBrowseLeafName": "Adenoid Cystic Carcinoma",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "T4265",
                            "ConditionBrowseLeafName": "Oral Cancer",
                            "ConditionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "ConditionBrowseBranchList": {
                    "ConditionBrowseBranch": [
                        {
                            "ConditionBrowseBranchAbbrev": "BC04",
                            "ConditionBrowseBranchName": "Neoplasms"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "All",
                            "ConditionBrowseBranchName": "All Conditions"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BC07",
                            "ConditionBrowseBranchName": "Mouth and Tooth Diseases"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "Rare",
                            "ConditionBrowseBranchName": "Rare Diseases"
                        }
                    ]
                }
            },
            "InterventionBrowseModule": {
                "InterventionMeshList": {
                    "InterventionMesh": [
                        {
                            "InterventionMeshId": "C000718244",
                            "InterventionMeshTerm": "Gallium 68 PSMA-11"
                        }
                    ]
                },
                "InterventionAncestorList": {
                    "InterventionAncestor": [
                        {
                            "InterventionAncestorId": "D000019275",
                            "InterventionAncestorTerm": "Radiopharmaceuticals"
                        },
                        {
                            "InterventionAncestorId": "D000045504",
                            "InterventionAncestorTerm": "Molecular Mechanisms of Pharmacological Action"
                        }
                    ]
                },
                "InterventionBrowseLeafList": {
                    "InterventionBrowseLeaf": [
                        {
                            "InterventionBrowseLeafId": "M351799",
                            "InterventionBrowseLeafName": "Gallium 68 PSMA-11",
                            "InterventionBrowseLeafAsFound": "Quadriceps",
                            "InterventionBrowseLeafRelevance": "high"
                        },
                        {
                            "InterventionBrowseLeafId": "M20948",
                            "InterventionBrowseLeafName": "Radiopharmaceuticals",
                            "InterventionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "InterventionBrowseBranchList": {
                    "InterventionBrowseBranch": [
                        {
                            "InterventionBrowseBranchAbbrev": "All",
                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                        }
                    ]
                }
            }
        }
    }
}